Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Pollak

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2000
A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in womenE Giovannucci, M N Pollak, E A Platz, et al.
European Journal of Clinical Nutrition|August 16, 2012
Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding studyS S Runchey, M N Pollak, L M Valsta, et al.
Genomics|May 15, 1996
The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumorsC M Phelan, C Larsson, S Baird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcomeW D Foulkes, P O Chappuis, N Wong, et al.
British Journal of Cancer|November 25, 2010
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumabA Gualberto, M L Hixon, D D Karp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancerW D Foulkes, N Wong, J S Brunet, et al.
British Journal of Cancer|May 30, 2007
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohortsB M Wolpin, D S Michaud, E L Giovannucci, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomyO Kucuk, F H Sarkar, W Sakr, et al.
Cancer|April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinomaJ N Ingle, V J Suman, C G Kardinal, et al.
Journal of the Neurological Sciences|January 4, 2001
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndromeD A Trojan, J Collet, M N Pollak, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2000
A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in womenE Giovannucci, M N Pollak, E A Platz, et al.
European Journal of Clinical Nutrition|August 16, 2012
Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding studyS S Runchey, M N Pollak, L M Valsta, et al.
Genomics|May 15, 1996
The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumorsC M Phelan, C Larsson, S Baird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcomeW D Foulkes, P O Chappuis, N Wong, et al.
British Journal of Cancer|November 25, 2010
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumabA Gualberto, M L Hixon, D D Karp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancerW D Foulkes, N Wong, J S Brunet, et al.
British Journal of Cancer|May 30, 2007
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohortsB M Wolpin, D S Michaud, E L Giovannucci, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomyO Kucuk, F H Sarkar, W Sakr, et al.
Cancer|April 3, 1999
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinomaJ N Ingle, V J Suman, C G Kardinal, et al.
Journal of the Neurological Sciences|January 4, 2001
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndromeD A Trojan, J Collet, M N Pollak, et al.
Pageof 4